← Back to Browse
ProductDiagnostic Tests

Circulating Tumor DNA (ctDNA) Detection Platform

China

An independently developed platform for detecting circulating tumor DNA with high sensitivity and specificity compared to traditional detection methods. This liquid biopsy approach enables non-invasive, painless diagnosis through a single blood sample for comprehensive cancer patient support.

Manufactured by

China

NOROVA specializes in personalized precision medicine for malignant tumors, serving as a biomedical innovation and life sciences R&D center in the Beijing-Tianjin region. The company operates a proprietary tumor organoid precision diagnosis platform integrating drug sensitivity testing, high-throughput drug screening, and genetic testing. NOROVA also develops tumor microenvironment organ-on-chip and multi-organ chip technologies for drug development applications.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

45
Relevant manufacturers
matched to this product
83
Relevant products analyzed
for supplier coverage
16
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

12 of 83 closest product alternatives

83 products

ctDNA Testing Platform

Burning Rock Dx Co. Ltd. · China

Circulating tumor DNA detection and analysis system for cancer diagnosis and monitoring. Enables early cancer detection through blood-based liquid biopsy technology with high sensitivity and specificity.

View Details

Tumor Liquid Biopsy Platform

guangzhou biotron technolongy co.,ltd · China

Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.

View Details

Liquid Biopsy Diagnostic Platform

GeneCker Co., Ltd. · South Korea

Integrated platform for cancer diagnosis utilizing liquid biopsy techniques with CRISPR/Cas9 technology. Includes complete workflow from sample collection through DNA sequencing to result analysis.

View Details

Circulating Tumor Cells (CTC) Detection System

Aliko Scientific SA · France

Liquid biopsy platform designed to detect and analyze circulating tumor cells in patient samples. Enables non-invasive cancer monitoring and personalized medicine applications through advanced genetic testing.

View Details

Cancer Genetic Testing Platform

Aliko Scientific SA · France

Advanced genetic testing platform for cancer diagnosis and personalized medicine applications. The system has been validated across thousands of real-world clinical scenarios for reliability and accuracy.

View Details

Early Cancer Detection Platform

GENETRON HEALTH (BEIJING) CO., LTD · China

Multi-biomarker screening solution for early-stage cancer identification. Analyzes blood samples to detect cancer-associated molecular signatures. Facilitates timely clinical intervention and improved patient outcomes.

View Details

Precision Medicine Diagnostic Platform

HealthTec Logix · Kuwait

Integrated diagnostic platform combining genomic sequencing with molecular analysis for precision medicine applications. Enables personalized treatment planning and early disease detection.

View Details

Cancer Drug Resistance Platform

HEMEX AG · Switzerland

Comprehensive cancer drug resistance diagnostic platform providing insights into treatment resistance mechanisms. Guides clinical decision-making for resistant cancer cases.

View Details

cf-SUPER ctDNA Analysis Technology

U-GEN BIOTECHNOLOGY INC. · China

Proprietary circulating tumor DNA analysis platform offering high accuracy and sensitivity for early cancer detection. Provides precision diagnosis for personalized cancer management and monitoring.

View Details

Molecular Diagnostics Platform

Guangzhou Wondfo Biotech Co., Ltd. · China

Molecular diagnostics platform for nucleic acid detection and amplification-based testing. Enables identification of pathogens and genetic markers for infectious disease and other molecular-based diagnoses.

View Details

Ultra-Fast detection of all Human Cancers using Non-Invasive liquid biopsy

Rapid Viral Detection Systems · United States

Point-of-care liquid biopsy platform for rapid cancer detection with 99% accuracy and high sensitivity. Delivers non-invasive screening results in minutes, enabling early diagnosis across multiple cancer types at a lower cost than conventional test kits.

View Details

EDGC-SCAN

Eone-Diagnomics Genome Center · South Korea

Liquid biopsy diagnostic platform for comprehensive genomic analysis and disease screening. Enables detection of genetic markers and abnormalities through blood-based testing.

View Details

71 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products